AstraZeneca Can't Stop Mylan's Generic Nexium At Fed. Circ.
The Federal Circuit on Monday rejected AstraZeneca AB's attempt to block Mylan Inc.'s generic version of blockbuster heartburn drug Nexium, clearing the way for additional copycat competition for the popular "purple...To view the full article, register now.
Already a subscriber? Click here to view full article